2021 Journal Article The AGE receptor, OST48 drives podocyte foot process effacement and basement membrane expansion (alters structural composition)Zhuang, Aowen, Yap, Felicia Y. T., Borg, Danielle J., McCarthy, Domenica, Fotheringham, Amelia, Leung, Sherman, Penfold, Sally A., Sourris, Karly C., Coughlan, Melinda T., Schulz, Benjamin L. and Forbes, Josephine M. (2021). The AGE receptor, OST48 drives podocyte foot process effacement and basement membrane expansion (alters structural composition). Endocrinology, Diabetes and Metabolism, 4 (3) e00278, e00278. doi: 10.1002/edm2.278 |
2020 Journal Article Going in early: hypoxia as a target for kidney disease prevention in diabetes?Barrett, Helen L., Donaghue, Kim C. and Forbes, Josephine M. (2020). Going in early: hypoxia as a target for kidney disease prevention in diabetes?. Diabetes, 69 (12), 2578-2580. doi: 10.2337/dbi20-0037 |
2020 Journal Article Circulating levels of the soluble receptor for AGE (sRAGE) during escalating oral glucose dosages and corresponding isoglycaemic i.v. glucose infusions in individuals with and without type 2 diabetesFotheringham, Amelia K., Bagger, Jonatan I., Borg, Danielle J., McCarthy, Domenica A., Holst, Jens J., Vilsbøll, Tina, Knop, Filip K. and Forbes, Josephine M. (2020). Circulating levels of the soluble receptor for AGE (sRAGE) during escalating oral glucose dosages and corresponding isoglycaemic i.v. glucose infusions in individuals with and without type 2 diabetes. Nutrients, 12 (10) 2928, 2928-12. doi: 10.3390/nu12102928 |
2020 Journal Article Transient intermittent hyperglycemia accelerates atherosclerosis by promoting myelopoiesisFlynn, Michelle C., Kraakman, Michael J., Tikellis, Christos, Lee, Man Ks, Hanssen, Nordin Mj, Kammoun, Helene L., Pickering, Raelene, Dragoljevic, Dragana, Al-Sharea, Annas, Barrett, Tessa J., Hortle, Fiona, Byrne, Frances L., Olzomer, Ellen, McCarthy, Domenica A., Schalkwijk, Casper G., Forbes, Josephine M., Hoehn, Kyle, Makowski, Liza, Lancaster, Graeme I., El-Osta, Assam, Fisher, Edward A., Goldberg, Ira J., Cooper, Mark E., Nagareddy, Prabhakara R., Thomas, Merlin C. and Murphy, Andrew J. (2020). Transient intermittent hyperglycemia accelerates atherosclerosis by promoting myelopoiesis. Circulation Research, 127 (7) CIRCRESAHA.120.316653, 877-892. doi: 10.1161/CIRCRESAHA.120.316653 |
2020 Journal Article Prolyl hydroxylase inhibitors: a breath of fresh air for diabetic kidney disease?Forbes, Josephine M. (2020). Prolyl hydroxylase inhibitors: a breath of fresh air for diabetic kidney disease?. Kidney International, 97 (5), 855-857. doi: 10.1016/j.kint.2020.01.038 |
2020 Journal Article Disruption of glycogen utilization markedly improves the efficacy of carboplatin against preclinical models of clear cell ovarian carcinomaKhan, Tashbib, He, Yaowu, Kryza, Thomas, Harrington, Brittney S., Gunter, Jennifer H., Sullivan, Mitchell A., Cuda, Tahleesa, Rogers, Rebecca, Davies, Claire M., Broomfield, Amy, Gough, Madeline, Wu, Andy C., McGann, Thomas, Weroha, S. John, Haluska, Paul, Forbes, Josephine M., Armes, Jane E., Barry, Sinead C., Coward, Jermaine I., Jagasia, Nisha, Chetty, Naven, Snell, Cameron E., Lourie, Rohan, Perrin, Lewis C. and Hooper, John D. (2020). Disruption of glycogen utilization markedly improves the efficacy of carboplatin against preclinical models of clear cell ovarian carcinoma. Cancers, 12 (4) 869, 869. doi: 10.3390/cancers12040869 |
2020 Journal Article Targeting the receptor for advanced glycation end products (RAGE) in type 1 diabetesLe Bagge, Selena, Fotheringham, Amelia K., Leung, Sherman S. and Forbes, Josephine M. (2020). Targeting the receptor for advanced glycation end products (RAGE) in type 1 diabetes. Medicinal Research Reviews, 40 (4) med.21654, 1200-1219. doi: 10.1002/med.21654 |
2020 Journal Article Delineating a role for the mitochondrial permeability transition pore in diabetic kidney disease by targeting cyclophilin DLindblom, Runa S. J., Higgins, Gavin C., Nguyen, Tuong-Vi, Arnstein, Maryann, Henstridge, Darren C., Granata, Cesare, Snelson, Matthew, Thallas-Bonke, Vicki, Cooper, Mark E., Forbes, Josephine M. and Coughlan, Melinda T. (2020). Delineating a role for the mitochondrial permeability transition pore in diabetic kidney disease by targeting cyclophilin D. Clinical Science, 134 (2), 239-259. doi: 10.1042/CS20190787 |
2019 Journal Article Complement C5a induces renal injury in diabetic kidney disease by disrupting mitochondrial metabolic agilityTan, Sih Min, Ziemann, Mark, Thallas-Bonke, Vicki, Snelson, Matthew, Kumar, Vinod, Laskowski, Adrienne, Nguyen, Tuong-Vi, Huynh, Kevin, Clarke, Michele V., Libianto, Renata, Baker, Scott T., Skene, Alison, Power, David A., MacIsaac, Richard J., Henstridge, Darren C., Wetsel, Rick A., El-Osta, Assam, Meikle, Peter J., Wilson, Scott G., Forbes, Josephine M., Cooper, Mark E., Ekinci, Elif I., Woodruff, Trent M. and Coughlan, Melinda T. (2019). Complement C5a induces renal injury in diabetic kidney disease by disrupting mitochondrial metabolic agility. Diabetes, 69 (1), 83-98. doi: 10.2337/db19-0043 |
2019 Journal Article Development and progression of non-alcoholic fatty liver disease: the role of advanced glycation end productsFernando, Dinali H., Forbes, Josephine M., Angus, Peter W. and Herath, Chandana B. (2019). Development and progression of non-alcoholic fatty liver disease: the role of advanced glycation end products. International Journal of Molecular Sciences, 20 (20) 5037, 5037. doi: 10.3390/ijms20205037 |
2019 Journal Article Genetic characterization of early renal changes in a novel mouse model of diabetic kidney diseaseBalmer, Lois A., Whiting, Rhiannon, Rudnicka, Caroline, Gallo, Linda A., Jandeleit, Karin A., Chow, Yan, Chow, Z., Richardson, Kirsty L., Forbes, Josephine M. and Morahan, G. (2019). Genetic characterization of early renal changes in a novel mouse model of diabetic kidney disease. Kidney International, 96 (4), 918-926. doi: 10.1016/j.kint.2019.04.031 |
2019 Journal Article Globally elevating the AGE clearance receptor, OST48, does not protect against the development of diabetic kidney disease, despite improving insulin secretionZhuang, Aowen, Yap, Felicia Y. T., McCarthy, Domenica, Leung, Chris, Sourris, Karly C., Penfold, Sally A., Thallas-Bonke, Vicki, Coughlan, Melinda T., Schulz, Benjamin L. and Forbes, Josephine M. (2019). Globally elevating the AGE clearance receptor, OST48, does not protect against the development of diabetic kidney disease, despite improving insulin secretion. Scientific Reports, 9 (1) 13664, 13664. doi: 10.1038/s41598-019-50221-0 |
2019 Journal Article Glucose and glycogen in the diabetic kidney: heroes or villains?Sullivan, Mitchell A. and Forbes, Josephine M. (2019). Glucose and glycogen in the diabetic kidney: heroes or villains?. EBioMedicine, 47, 590-597. doi: 10.1016/j.ebiom.2019.07.067 |
2019 Journal Article Response to Letter to the Editor: "Advanced Glycation End Products and esRAGE Are Associated With Bone Turnover and Incidence of Hip Fracture in Older Men"Lamb, Lydia S., Davis, Timothy M E, Forbes, Josephine, Irrgang, Felix, Golledge, Jonathan, Flicker, Leon and Yeap, Bu B. (2019). Response to Letter to the Editor: "Advanced Glycation End Products and esRAGE Are Associated With Bone Turnover and Incidence of Hip Fracture in Older Men". Journal of Clinical Endocrinology and Metabolism, 104 (3), 684-685. doi: 10.1210/jc.2018-02198 |
2019 Conference Publication Exploring AGE and sRAGE regulation in response to oral and intravenous glucose loads in individuals with recently diagnosed type 2 diabetesFotheringham, A. K., Bagger, J. I., Borg, D. J., McCarthy, D., Vilsboll, T., Knop, F. K. and Forbes, J. M. (2019). Exploring AGE and sRAGE regulation in response to oral and intravenous glucose loads in individuals with recently diagnosed type 2 diabetes. 55th Annual Meeting of the European Association for the Study of Diabetes (EASD), Barcelona, Spain, 16-20 September 2019 . New York, NY, United States: Springer. |
2019 Conference Publication Complement C5a induces renal injury in diabetic kidney disease via mitochondrial reprogrammingCoughlan, M. T., Tan, S., Ziemann, M., Snelson, M., El-Osta, A., MacIsaac, R. J., Meikle, P. J., Forbes, J. M., Cooper, M. E., Ekinci, E. I. and Woodruff, T. M. (2019). Complement C5a induces renal injury in diabetic kidney disease via mitochondrial reprogramming. 55th Annual Meeting of the European-Association-for-the-Study-of-Diabetes (EASD), Barcelona Spain, 16-20 September 2019. Heidelberg, Germany: Springer. |
2019 Journal Article The effect of a low carbohydrate formula on glycaemia in critically ill enterally-fed adult patients with hyperglycaemia: a blinded randomised feasibility trialDoola, Ra'eesa, Deane, Adam M., Tolcher, Debbie M., Presneill, Jeffrey J., Barrett, Helen L., Forbes, Josephine M., Todd, Alwyn S., Okano, Satomi and Sturgess, David J. (2019). The effect of a low carbohydrate formula on glycaemia in critically ill enterally-fed adult patients with hyperglycaemia: a blinded randomised feasibility trial. Clinical Nutrition ESPEN, 31, 80-87. doi: 10.1016/j.clnesp.2019.02.013 |
2018 Journal Article Advanced Glycation End Products and esRAGE Are Associated With Bone Turnover and Incidence of Hip Fracture in Older MenLamb, Lydia S., Alfonso, Helman, Norman, Paul E., Davis, Timothy M. E., Forbes, Josephine, Müench, Gerald, Irrgang, Felix, Almeida, Osvaldo P., Golledge, Jonathan, Hankey, Graeme J., Flicker, Leon and Yeap, Bu B. (2018). Advanced Glycation End Products and esRAGE Are Associated With Bone Turnover and Incidence of Hip Fracture in Older Men. Journal of Clinical Endocrinology and Metabolism, 103 (11), 4224-4231. doi: 10.1210/jc.2018-00674 |
2018 Conference Publication GLYCOGEN IN THE DIABETIC KIDNEY: THE HERO OR THE VILLAIN?Sullivan, M. A., Wang, Z., Li, I., Milton, L., Mccarthy, D., Harcourt, B. E., Penfold, S. and Forbes, J. M. (2018). GLYCOGEN IN THE DIABETIC KIDNEY: THE HERO OR THE VILLAIN?. HOBOKEN: WILEY. |
2018 Conference Publication Circulating advanced glycation end products and their endogenous secretory receptor are associated with bone turnover markers and with incidence of hip fracture in older menLamb, Lydia, Alfonso, Helman, Norman, Paul E., Davis, Timothy M. E., Forbes, Josephine, Muench, Gerald and Yeap, Bu B. (2018). Circulating advanced glycation end products and their endogenous secretory receptor are associated with bone turnover markers and with incidence of hip fracture in older men. Joint Annual Scientific Meetings of Endocrine-Society-of-Australia (ESA) and Society-for-Reproductive-Biology (SRB), Perth Australia, Aug 27-30, 2017. HOBOKEN: WILEY. |